The ingredients are not on the packaging, and the warnings of side effects are downplayed, but still, the shots go on.
Now, however, some really out of left field things are going on with people who have received just about all of the experimental gene therapies known as COVID “vaccines,” that one government entity is taking a closer look as to whether or not rare maladies are actually side effects.
Three new conditions reported by a small number of people after vaccination with COVID-19 shots from Pfizer (PFE.N) and Moderna (MRNA.O) are being studied to assess if they may be possible side effects, Europe’s drugs regulator said on Wednesday.
Erythema multiforme, a form of allergic skin reaction; glomerulonephritis or kidney inflammation; and nephrotic syndrome, a renal disorder characterized by heavy urinary protein losses, are being studied by the safety committee of the European Medicines Agency (EMA), according to the regulator.
Blood clotting, sudden heart issues in the young and healthy, women having heavy menstrual issues even after menopause, Guillian Barre Syndrome, and more have been reported as side effects to the shots, but kidney issues are new.
How this is happening is not known in the mainstream. At least Europe is looking into it.
Last month, the EMA found a possible link between very rare heart inflammation and the mRNA vaccines. However, the European regulator and the World Health Organization have stressed that the benefits from these vaccines outweigh any risks.
The watchdog did not give details on Wednesday on how many cases of the new conditions were recorded but said it had requested more data from the companies. The EMA did not recommend changes to the labeling of the vaccines.
It disclosed the new assessments as part of routine updates to the safety section of all authorized vaccines’ databases and added menstrual disorders as a condition it was studying for vaccines, including those from AstraZeneca (AZN.L) and J&J (JNJ.N), after the EMA’s update last week.